Treatment of post-bariatric hypoglycemia using mini-dose stable glucagon

A technology of glucagon and hypoglycemia, which is applied in the field of treating hypoglycemia after weight loss, and can solve problems such as inability to relieve symptoms

Pending Publication Date: 2020-11-13
XERIS PHARMA INC +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Unlike dumping, nutritional manipulation does not alleviate symptoms of postprandial hypoglycemia (PPH)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0080] Randomized, placebo-controlled, double-blind, two-way crossover study followed by open-label crossover extension with standard of care to assess the incidence and duration of postprandial hypoglycemia in patients following bariatric surgery

[0081] The primary objective of the described study was to assess the incidence and duration of postprandial hypoglycemia (PG below 70 mg / dL). To assess (i) prevention of postprandial hypoglycemic episodes (defined as glucose levels below 70 mg / dl); (ii) prevention of severe hypoglycemic episodes (defined as glucose levels below 54 mg / dl); prevention of Rebound hyperglycemia (defined as glucose levels above 180 mg / dl) was used as a secondary goal. Time in target range (defined as glucose levels of 70 mg / dl to 180 mg / dl), reported in minutes, should also be assessed; and the neurologicity of hypoglycemia recorded using the Edinburgh Hypoglycemia Symptoms Score Originating symptoms (if present).

[0082]Additional objectives includ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Post-bariatric hypoglycemia (PBH) is an increasingly-recognized complication of gastric bypass surgery. Current therapeutic options have suboptimal efficacy. Small doses of stable liquid glucagon canbe used to treat or prevent post-bariatric hypoglycemia.

Description

[0001] Statement Regarding Federally Funded Research [0002] This invention was made with Government support under Grant No. R44DK107114 awarded by the U.S. Department of Health and Human Services. The government has certain rights in this invention. technical field [0003] The present invention relates to the fields of bariatric medicine and surgery. In particular aspects, the invention relates to methods for treating post-bariatric hypoglycemia (PBH). Background technique [0004] An abnormal increase in insulin secretion can lead to severe hypoglycemia, or low blood sugar, a state that can lead to serious illness including seizures and brain damage. Drug-induced hypoglycemia may be due to overdose of sulfonylureas or insulin. Many medical conditions are characterized by non-drug-induced endogenous hyperinsulinemic hypoglycemia, such as hyperinsulinemic hypoglycemia following gastric bypass surgery. [0005] Hypoglycemia can lead to a variety of symptoms, including l...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/26A61K9/00A61K9/08A61K47/02A61K47/20A61K47/26A61P1/18A61P3/08A61P5/48
CPCA61K38/26A61K9/0019A61K9/0021A61K47/20A61K47/26A61K9/08A61P3/08A61P5/48A61P1/18A61K47/02A61K47/10
Inventor 布雷特·纽尼斯万格史蒂夫·J·普莱斯特斯基玛丽-伊丽莎白·帕蒂
Owner XERIS PHARMA INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap